Lübeck P, Orgül S, Gugleta K, Gherghel D, Gekkieva M, Flammer J
University Eye Clinic, Basel, Switzerland.
J Glaucoma. 2001 Feb;10(1):13-7. doi: 10.1097/00061198-200102000-00004.
To evaluate the effect of 0.5% timolol maleate on the capillary circulation of the anterior optic nerve head in patients with primary open-angle glaucoma and to compare the results with those obtained in a healthy control group.
Twelve patients with nonprogressive glaucoma and 12 age- and sex-matched healthy volunteers were included in this prospective study. Optic nerve head perfusion was examined by the Heidelberg Retina Flowmeter (HRF) in both groups. A 3-week washout period preceded the baseline measurement in the glaucoma group, and ONH blood flow was assessed again after 3 weeks of bilateral topical timolol treatment and 2 hours after timolol application.
Intraocular pressure decreased significantly with timolol (P < 0.001). The HRF flow values for patients with glaucoma were comparable to those for a control group at baseline (P = 0.25), 3 weeks after timolol therapy (P = 0.09), and 2 hours after timolol instillation (P = 0.15). The glaucoma group showed no statistically significant change in the HRF parameter flow as compared with baseline, either after 3 weeks of timolol treatment or 2 hours after timolol instillation (P = 0.40). The heart rate and arterial systolic and diastolic blood pressure values showed no alteration after timolol therapy.
Patients with nonprogressive glaucoma seem not to have an altered optic nerve blood flow as assessed by the HRF, and timolol treatment does not seem to alter the latter blood flow parameter in such patients.
评估0.5%马来酸噻吗洛尔对原发性开角型青光眼患者视神经乳头前部毛细血管循环的影响,并将结果与健康对照组进行比较。
本前瞻性研究纳入了12例非进行性青光眼患者和12例年龄及性别匹配的健康志愿者。两组均采用海德堡视网膜血流仪(HRF)检查视神经乳头灌注情况。青光眼组在基线测量前有3周的洗脱期,在双侧局部应用噻吗洛尔3周后及应用噻吗洛尔2小时后再次评估视神经乳头血流。
噻吗洛尔使眼压显著降低(P < 0.001)。青光眼患者的HRF血流值在基线时(P = 0.25)、噻吗洛尔治疗3周后(P = 0.09)以及滴注噻吗洛尔2小时后(P = 0.15)与对照组相当。与基线相比,青光眼组在噻吗洛尔治疗3周后或滴注噻吗洛尔2小时后,HRF参数血流均无统计学显著变化(P = 0.40)。噻吗洛尔治疗后心率及动脉收缩压和舒张压值均无改变。
通过HRF评估,非进行性青光眼患者的视神经血流似乎未改变,噻吗洛尔治疗似乎也不会改变此类患者的后一项血流参数。